Home » IMI EXPANDS SKIN STEROL RESEARCH WITH STUDY EXAMINING NEW CARDIOVASCULAR DISEASE MARKERS
IMI EXPANDS SKIN STEROL RESEARCH WITH STUDY EXAMINING NEW CARDIOVASCULAR DISEASE MARKERS
Predictive medicine company IMI International Medical Innovations will initiate a new clinical trial to evaluate the relationship between skin sterol values and a variety of new and established coronary artery disease markers, including ankle/brachial blood pressure index and vascular compliance, in high-risk patients.
Canada NewsWire (http://www.newswire.ca/en/releases/archive/January2005/05/c9947.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct